Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01412086 · ClinicalTrials.gov registry record
Inter-rater and Intra-rater Reliability of the Global Eyebrow Assessment Scale
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 112
- Enrollment target
NCT01412086 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 112 participants.
The verdict
NCT01412086 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 112 participants
- Enrollment target
Study Summary
This study evaluated the inter- and intra-rater reliability of the GEBA Scale with photonumeric guide for the assessment of overall eyebrow fullness. There is no treatment (intervention) associated with this study.
Interventions
- DRUG No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2011-08 |
| Est. Completion | 2011-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01412086
The ClinicalTrials.gov registry entry for NCT01412086 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT01412086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01412086 about?
NCT01412086 is a clinical study titled "Inter-rater and Intra-rater Reliability of the Global Eyebrow Assessment Scale". This study evaluated the inter- and intra-rater reliability of the GEBA Scale with photonumeric guide for the assessment of overall eyebrow fullness. There is no treatment (intervention) associated with this study.
What is the current status of trial NCT01412086?
This trial is currently completed. The enrollment target is 112 participants. The study started on 2011-08. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01412086?
The interventions under investigation include: No Intervention (DRUG).
Who is sponsoring clinical trial NCT01412086?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.